Skip to main content
SpringerLink
Log in

High-performance thin-layer chromatography-based methodology for simultaneous estimation of bisoprolol fumarate and telmisartan

  • Original Research Paper
  • Published:
JPC – Journal of Planar Chromatography – Modern TLC Aims and scope Submit manuscript

Abstract

Bisoprolol fumarate (BSF) is a cardioselective β-blocker, whereas telmisartan (TLM) is an angiotensin II receptor antagonist. Both drugs in combination are available as a formulation product effective in the management of hypertension. As a rapid and precise analytical method, there is still no high-performance thin-layer chromatographic (HPTLC) method reported for the simultaneous estimation of both the drugs in combination. Therefore, the aim of the present study was to develop a precise, accurate, and sensitive HPTLC method for simultaneous estimation of BSF and TLM in bulk and in formulation product. The separation was achieved by using a mobile phase mixture consisting of methanol‒ethyl acetate‒glacial acetic acid (MeOH‒EA‒GAA; 6:4:0.1, V/V). The retention factor (RF) for BSF and TLM was found to be 0.435 ± 0.04 and 0.699 ± 0.04, respectively, and the peak areas were determined at 231 nm. The method was subsequently validated as per the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q2 (R1) guidelines. A linear relationship was obtained between the concentration ranges and peak areas with correlation coefficient (R2) ≥ 0.999. The developed method was found to be accurate, precise, and robust. The method was then applied for analysis of three different batches of marketed product, and the percent content for BSF and TLM in the formulation was found to be > 98.0% w/w.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig.1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bloch MJ (2016) Worldwide prevalence of hypertension exceeds 1.3 billion. J Am Soc Hypertens 10:753–754. https://doi.org/10.1016/j.jash.2016.08.006

    Article  PubMed  Google Scholar 

  2. Zhou B, Carrillo-Larco RM, Danaei G et al (2021) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet 398:957–980. https://doi.org/10.1016/S0140-6736(21)01330-1

    Article  Google Scholar 

  3. Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16:223–237. https://doi.org/10.1038/s41581-019-0244-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Campbell NRC, Ordunez P, DiPette DJ et al (2018) Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League. J Clin Hypertens 20:984–990. https://doi.org/10.1111/jch.13307

    Article  Google Scholar 

  5. Taddei S (2015) Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence? Am J Cardiovasc Drugs 15:185–194. https://doi.org/10.1007/s40256-015-0116-5

    Article  CAS  PubMed  Google Scholar 

  6. Leopold G, Ungethum W, Pabst J et al (1986) Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist. Br J Clin Pharmacol 22:293–300. https://doi.org/10.1111/j.1365-2125.1986.tb02890.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gorre F, Vandekerckhove H (2010) Beta-blockers: focus on mechanism of action which beta-blocker, when and why? Acta Cardiol 65:565–570. https://doi.org/10.1080/AC.65.5.2056244

    Article  PubMed  Google Scholar 

  8. National Center for Biotechnology Information PubChem Compound Summary for CID 6917733, Bisoprolol monofumarate. https://pubchem.ncbi.nlm.nih.gov/compound/Bisoprolol-monofumarate. Accessed 6 Feb 2024

  9. Kim HK, Youm JB, Lee SR et al (2012) The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action. Pflugers Arch 464:631–643. https://doi.org/10.1007/s00424-012-1170-3

    Article  CAS  PubMed  Google Scholar 

  10. Battershill AJ, Scott LJ (2006) Telmisartan. Drugs 66:51–83. https://doi.org/10.2165/00003495-200666010-00004

    Article  CAS  PubMed  Google Scholar 

  11. National Center for Biotechnology Information PubChem Compound Summary for CID 65999, Telmisartan. https://pubchem.ncbi.nlm.nih.gov/compound/Telmisartan. Accessed 6 Feb 2024

  12. Sawhney J, Garg R, Makkar J et al (2023) Consensus towards the utilisation of bisoprolol in combination with telmisartan in Indian patients with hypertension. J Hypertens 41:e122. https://doi.org/10.1097/01.hjh.0000939996.02952.4f

    Article  Google Scholar 

  13. Joshi SJ, Karbhari PA, Bhoir SI et al (2010) RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation. J Pharm Biomed Anal 52:362–371. https://doi.org/10.1016/j.jpba.2009.10.021

    Article  CAS  PubMed  Google Scholar 

  14. Kurade V, Pai M, Gude R (2009) RP-HPLC estimation of ramipril and telmisartan in tablets. Indian J Pharm Sci 71:148. https://doi.org/10.4103/0250-474X.54283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mukhopadhyay S, Kadam K, Sawant L et al (2011) Simultaneous determination of related substances of telmisartan and hydrochlorothiazide in tablet dosage form by using reversed phase high performance liquid chromatographic method. J Pharm Bioallied Sci 3:375. https://doi.org/10.4103/0975-7406.84441

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mahaparale SP, Gonjari ID, Jayaveera KN (2013) Stability indicating HPLC method for simultaneous estimation of metoprolol succinate and telmisartan. J Liq Chromatogr Relat Technol 36:2601–2611. https://doi.org/10.1080/10826076.2012.723095

    Article  CAS  Google Scholar 

  17. Gholve RB, Pekamwar SS, Kalyankar TM (2021) Stability-indicating RP-HPLC method development and validation for simultaneous estimation of bisoprolol fumarate and amlodipine besylate in bulk and in tablet dosage form. J Appl Pharm Sci. https://doi.org/10.7324/JAPS.2021.1101211

    Article  Google Scholar 

  18. Fernandez-Lopez L, Pellegrini M, Rotolo MC et al (2019) Development and validation of a method for the analysis of bisoprolol and atenolol in human bone. Molecules 24:2400. https://doi.org/10.3390/molecules24132400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Caudron E, Laurent S, Billaud EM, Prognon P (2004) Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography. J Chromatogr B 801:339–345. https://doi.org/10.1016/j.jchromb.2003.11.009

    Article  CAS  Google Scholar 

  20. Mohammed SA, Adam ME, Shantier SW (2017) Development and validation of UV spectrophotometric method for determination of bisoprolol fumarate in bulk and pharmaceutical dosage forms. Mediterr J Chem 6:196–199. https://doi.org/10.13171/mjc65/01710181149-shantier

    Article  CAS  Google Scholar 

  21. Chivate ND, Patil SM, Saboji JK, Chivate AN (2012) Development of UV spectrophotometric method for estimation and validation of Telmisartan as a pure API. J Pharm Res 5:3331–3333

    CAS  Google Scholar 

  22. Ramzy S, Abdelazim AH, Shahin M (2022) Quantitative analysis of two pharmaceutical combinations containing amlodipine with either bisoprolol or candesartan using different UV spectrophotometric methods. J AOAC Int 105:1200–1204. https://doi.org/10.1093/jaoacint/qsac018

    Article  PubMed  Google Scholar 

  23. Attimarad M, Chohan MS, Elgorashe REE (2020) Smart analysis of a ternary mixture of amlodipine, hydrochlorothiazide and telmisartan by manipulation of UV spectra: development, validation and application to formulations. J Mol Struct 1212:128095. https://doi.org/10.1016/j.molstruc.2020.128095

    Article  CAS  Google Scholar 

  24. Prabhu C, Subramanian G, Karthik A et al (2007) Determination of telmisartan by HPTLC—A stability indicating assay. J Planar Chromatogr—Mod TLC 20:477–481. https://doi.org/10.1556/JPC.20.2007.6.14

    Article  CAS  Google Scholar 

  25. Witek A, Hopkala H, Matysik G (1999) TLC-densitometric determination of bisoprolol, labetalol and propafenone, as dabsyl derivatives, in pharmaceutical preparations. Chromatographia 50:41–44. https://doi.org/10.1007/BF02493615

    Article  CAS  Google Scholar 

  26. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (2005) ICH harmonised tripartite guideline validation of analytical procedures: text and methodology Q2(R1) https://database.ich.org/sites/default/files/Q2_R1__Guideline.pdf

  27. Bakheit AHH, Abd-Elgalil AA, Mustafa B et al (2015) Telmisartan. Profiles of Drug Substances. Excipients and Related Methodology. Academic Press Inc., Cambridge, pp 371–429

    Google Scholar 

  28. Bakheit AH, Ali R, Alshahrani AD, El-Azab AS (2021) Bisoprolol: A comprehensive profile. Profiles of Drug Substances, Excipients and Related Methodology. Academic Press Inc., Cambridge, pp 51–89

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Quality Assurance Techniques, Poona College of Pharmacy, Bharati Vidyapeeth Deemed to Be University, Pune, Maharashtra, 411038, India

    Sumit Gunjal, Hemant Jain & Sandeep Sankaran

  2. Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth Deemed to Be University, Pune, Maharashtra, 411038, India

    Savita Yadav

Authors
  1. Sumit Gunjal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hemant Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandeep Sankaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Savita Yadav
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

H.J., S.Y., and S.S. contributed to the study’s conceptualization and design. S.G. handled the material preparation, data collection, and analysis, as well as drafted the text, which was then edited and modified by all authors. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hemant Jain.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gunjal, S., Jain, H., Sankaran, S. et al. High-performance thin-layer chromatography-based methodology for simultaneous estimation of bisoprolol fumarate and telmisartan. JPC-J Planar Chromat (2024). https://doi.org/10.1007/s00764-024-00291-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00764-024-00291-2

Keywords

Search

Navigation